|
"Genetic interactions between Tgfb1 and Skts15/Tgfbm3 in cancer"
|
5R01CA116019-02
|
$296,906
|
$148,453
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research
|
5P20CA192988-02
|
$190,237
|
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQB2) Identification of Tumor-Derived Activators of Anti-Cancer Immune Responses
|
5R21CA190072-02
|
$180,843
|
|
SUNWOO, JOHN
|
STANFORD UNIVERSITY
|
|
(PQC1) PLK1 And EPHX3 Promotion Of Genomic Instability In Bronchial Dysplasia
|
5R21CA190124-02
|
$172,656
|
|
MERRICK, DANIEL
|
UNIVERSITY OF COLORADO DENVER
|
|
(PQC4) Imaging CD8 T Cells In Tumor Immunotherapy By Immunopet
|
5R21CA190044-02
|
$200,970
|
|
WU, ANNA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care
|
5R01CA190016-02
|
$680,845
|
|
NATTINGER, ANN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
1/2 Howard/Hopkins Intercenter Collaboration in HPV-Associated Cancer Studies
|
5P20CA192989-02
|
$179,297
|
|
PANG, XIAOWU
|
HOWARD UNIVERSITY
|
|
1/2-Regional Geohealth Hub Centered in Peru-Peru
|
1U01TW010107-01
|
$224,955
|
|
GONZALES, GUSTAVO
|
UNIVERSIDAD PERUANA CAYETANO HEREDIA
|
|
17th IMS New Researchers Conference
|
1R13CA200282-01
|
$16,140
|
|
SIMON, NOAH
|
UNIVERSITY OF WASHINGTON
|
|
2/2-Air Pollution and Health GeoHealth Hub Research and Capacity Building-US
|
1U2RTW010108-01
|
$224,999
|
|
CASH, RICHARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
2/2-Regional Geohealth Hub Centered in Peru-US
|
1U2RTW010114-01
|
$224,871
|
|
Steenland, Nelson
|
EMORY UNIVERSITY
|
|
2008 International Symposium
|
1R13CA135806-01
|
$7,000
|
$3,500
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
2015-E03B/OVARIAN CANCER CHEMOPREVENTION (SHETA2)
|
261201500041I
|
$513,187
|
|
UNKNOWN, UNKNOWN
|
SRI INTERNATIONAL
|
|
3D Photoacoustic Tomography (PAT)and Dynamic Contrast-Enhanced PAT Breast Imaging
|
5R01CA160850-04
|
$654,907
|
|
KRUGER, ROBERT
|
OPTOSONICS, INC.
|
|
3D-Adhesion Stromagenesis in Cancer Permissiveness
|
5R01CA113451-09
|
$334,387
|
|
CUKIERMAN, EDNA
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
4C and Genome Editing for Causal SNP and Gene Discovery at Cancer Risk Loci
|
1R21CA191725-01A1
|
$223,181
|
|
FREEDMAN, MATTHEW
|
DANA-FARBER CANCER INST
|
|
A chemical biology approach towards understanding the anti-cancer innate immunity
|
4R00CA190896-02
|
$248,961
|
|
LI, LINGYIN
|
STANFORD UNIVERSITY
|
|
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnos
|
1U01DK108300-01
|
$190,000
|
|
Park, Walter
|
STANFORD UNIVERSITY
|
|
A comparison of interventions to teach melanoma patients' skin self-examination
|
5R01CA154908-05
|
$515,336
|
|
ROBINSON, JUNE
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
A computer aided chromosome imaging technique for cancer diagnosis
|
5R01CA115320-03
|
$312,688
|
$62,538
|
Liu, Hong
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
A Computer Tool for Aiding in Accurate Assessment of Indeterminate Lung Nodules
|
1R43CA203058-01
|
$149,970
|
|
PU, JIANTAO
|
INTERNATIONAL INTELLIGENT INFOR/SOLU/LAB
|
|
A Fully Synthetic Carbohydrate-based Cancer Vaccine
|
5R01CA088986-13
|
$357,619
|
|
BOONS, GEERT-JAN
|
UNIVERSITY OF GEORGIA
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$460,324
|
|
Barchi, Joseph
|
CCR (NCI)
|
|
A High-Throughput Model for Human Melanoma
|
5R01CA121118-02
|
$189,600
|
$189,600
|
HOLMEN, SHERI
|
NEVADA CANCER INSTITUTE
|
|
A Model for Individualized Risk Prediction of Contralateral Breast Cancer
|
5R21CA186086-02
|
$174,946
|
|
BISWAS, SWATI
|
UNIVERSITY OF TEXAS DALLAS
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$109,366
|
|
Mock, Beverly
|
CCR (NCI)
|
|
A molecular method to determine isoform frequencies in RNA-seq
|
1R21CA196438-01
|
$269,483
|
|
WELSH, JOHN
|
VACCINE RESEARCH INSTITUTE OF SAN DIEGO
|
|
A mouse model for p120 downregulation in cancer
|
5R01CA111947-04
|
$287,369
|
$57,474
|
REYNOLDS, ALBERT
|
VANDERBILT UNIVERSITY
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
5R01CA183252-02
|
$538,425
|
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Mouse model of TGFbeta1 and ras oncogene interactions
|
5R01CA122109-03
|
$240,628
|
$240,628
|
GLICK, ADAM
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
A mouse model of TGFbeta1 and tumor immunosurveillance in Squamous cell cancer
|
5R01CA117957-03
|
$215,636
|
$215,636
|
GLICK, ADAM
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
A nanosystem for tumor treatment and imaging
|
5R01CA188883-02
|
$404,625
|
|
RUOSLAHTI, ERKKI
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
|
1R01CA175318-01A1
|
$354,563
|
|
HATEFI, ARASH
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
1R01CA190776-01
|
$666,229
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
|
7R01CA190696-02
|
$312,436
|
|
SCHATZ, JONATHAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A next-generation Integrative Genomics Viewer for biomedical and cancer research.
|
7R01CA157304-05
|
$462,627
|
|
MESIROV, JILL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
A Non-Invasive Method to Distinguish Melanomas from Benign Skin Lesions
|
1R43CA128247-01A1
|
$100,000
|
$100,000
|
Klukkert, Zachary
|
DERMATEX, LLC
|
|
A novel lineage pathway controls metabolic adaptation by metastatic lung cancers
|
1R01CA191489-01
|
$380,278
|
|
NGUYEN, DON
|
YALE UNIVERSITY
|
|
A Novel Mechanism for Drugs Targeting the CRM1 Nuclear Export Protein in Leukemia
|
1R03CA191983-01A1
|
$79,500
|
|
LAVAU, CATHERINE
|
DUKE UNIVERSITY
|
|
A Novel Mechanism of GTPase Regulation: Arl2 Interaction with TBCD
|
5F31CA189672-02
|
$43,120
|
|
FRANCIS, JOSHUA
|
EMORY UNIVERSITY
|
|
A novel multi-targeted therapy for breast cancer resistance
|
1R21CA184573-01A1
|
$206,190
|
|
BROUXHON, SABINE
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
A novel pathway to clear cells of misfolded proteins
|
ZIA BC 011628
|
$332,539
|
|
Walters, Kylie
|
CCR (NCI)
|
|
A Novel Role for PML bodies in Leukemic Transformation
|
5F32CA189413-02
|
$56,042
|
|
COGSWELL, ALEXIS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
|
4R44CA183287-02
|
$1,051,862
|
|
MURASKI, JOHN
|
ENDURX PHARMACEUTICALS, INC.
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-05
|
$292,333
|
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
A Novel Treatment to Target Tumor Mass for Eradicating Metastasis
|
1R43CA130182-01A1
|
$200,435
|
$200,435
|
Bao, Yun
|
BIOCHAIN INSTITUTE, INC.
|
|
A Novel Vaccination Stratagem for Lung Cancer
|
1R21CA198249-01
|
$195,750
|
|
YADDANAPUDI, KAVITHA
|
UNIVERSITY OF LOUISVILLE
|
|
A p53/NFkB-mediated metabolic mechanism for chemotherapy protection
|
5R01CA183074-02
|
$335,113
|
|
YUAN, ZHI-MIN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
A Pathway of Tumor Suppression
|
5R01CA047296-27
|
$249,580
|
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A program of immune-based treatments for cancer
|
2K24CA093670-06
|
$178,300
|
$89,150
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Skin for this search: $190,565,481
|